Pleightlet

N/A

Report date: 2025/05/12 17:03:55

Base Information

Drug NamePleightlet
Drug Alias NameAutologous CD34+ peripheral blood stem cells (Medical College of Wisconsin)自体CD34 +外周血干细胞-威斯康星医学院
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Medical College Of Wisconsin Nonprofit
China Registration ClassN/A

Develop Information

Active CompaniesThe Medical College Of Wisconsin Nonprofit
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A